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Abstract (100 words) 
 
Ovothiols are sulfur-containing natural products biosynthesized by marine invertebrates, 
microalgae, and bacteria. These compounds are characterized by unique chemical properties 
suggestive of numerous cellular functions. For example, ovothiols may be cytoprotectants against 
oxidative stress, serve as building blocks of more complex structures and may act as molecular 
messengers for inter- and intracellular signaling. Detailed understanding of ovothiol physiological 
role in marine organisms may unearth novel concepts in cellular redox biochemistry and highlight 
the therapeutic potential of this antioxidant. The recent discovery of ovothiol biosynthetic genes has 
paved the way for a systematic investigation of ovothiol-modulated cellular processes. In this 
highlight we review the early research on ovothiol and we discuss key questions that may now be 
addressed using genome-based approaches.  
 
This highlight article provides an overview of recent progress towards elucidating the biosynthesis, 
function and potential application of ovothiols. 
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 Background and open challenges  
 
The extraordinary beauty of marine landscapes has always inspired scientists and artists for 
the huge richness in biodiversity, reflecting billions of years of evolution. Marine diversity also 
extends to molecular scales making the oceans one of the largest repositories for natural products 
with amazing structures and potentially life-saving therapeutic activities1. One particularly 
interesting group of natural compounds are sulphur-containing molecules because of their ability to 
participate in cellular redox chemistry. Low-molecular-weight thiols, thiones, thioethers and 
disulfides play a key role in maintaining cellular redox homeostasis and enable organisms to survive 
taxing and changing environmental conditions.2,3 Probably one of the most abundant, yet least 
investigated marine sulfur compound is ovothiol A (1, Figure 1). This 5-thiohistidine has been 
isolated for the first time from sea urchin eggs, which resulted in its naming ovothiol.4,5,6 The 
unique antioxidant properties7,8,9 and the broad distribution among marine invertebrates, microalgae 
and proteobacteria provide reason to believe that ovothiol A and its derivatives ovothiol B and C (2 
& 3, Figure 1) play important roles in cellular biochemistry.10,11   
In the past, systematic investigations on the physiological function of thiohistidines were 
difficult, because the origin and distribution of these compounds was obscure. The recent 
identification of ovothiol biosynthetic genes10 and the growing availability of sequenced genomes 
from bacteria, fungi and higher eukaryotes, have opened new avenues to examine several key 
questions, including those about i) the evolutionary origin of ovothiols ii) the distribution of 
ovothiol biosynthetic genes among extant marine organisms iii) the catalytic mechanisms of 
ovothiol biosynthetic enzymes and most importantly, iv) the physiological role of ovothiol. 
Answers to these questions are likely to uncover novel concepts in redox biochemistry and may also 
inspire the development of novel therapeutic approaches and biotechnological applications based on 
thio-histidines. 
           The objective of this article is to summarize current answers to these questions. We 
will also identify future challenges and discuss how bioinformatics, comparative and functional 
genomics, structural biology and enzymology should be combined to develop a comprehensive 
perspective on ovothiols in marine organisms, and to unravel the potential of ovothiol biosynthesis 
in the emerging research field of blue biotechnology.  
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 Occurrence of ovothiol and related marine thiohistidines 
Almost forty years ago ovothiols were recognized as common metabolites in marine invertebrates. 
Ovothiol A, 5(Nπ)-methyl thiohistidine (1, Figure 1) was isolated from the eggs of the sea urchins 
Paracentrotus lividus
4, and Arbacia lixula, in the holothuroid, Holothuria tubulosa, the asteroids, 
Astropecten aurantiacus and Marthasterias glacialis5, the mottled sea star, Evasteria stroschelii7, in 
the eggs and biological fluids of molluscs, the common octopus Octopus vulgaris and the europeans 
squid Loligo vulgaris6, in the celomic fluid of the marine worm, Platynereis dumerilii12. The ovothiol 
derivatives B and C (2 and 3, Figure 1) are distinguished from A by one or two additional methyl 
group at the α-amino function of 5-thiohistidine. These compounds were first discovered in the eggs 
of the spiny scallop Chlamys hastata7 and in the eggs of the purple sea urchin Strongylocentrotus 
purpuratus
8 and Sphaerechinus granularis.5  
Ovothiol A, and its N-desmethyl form 5-thiohistidine were also found as building blocks of 
more complex secondary metabolites from marine invertebrates. Adenochromine, an iron-binding 
purple pigment isolated from the common octopus (Octopus vulgaris) was found to consist of a 
dihydroxy phenylalanine core (DOPA) attached to two ovothiol A or 5-thiohistidine moieties13 (4 – 
6, Figure 1). Other examples include the Discorhabdins J, K and M (7 – 9) isolated from marine 
sponges Latrunculia brevis14, and the cytotoxic alkaloid imbricatine (10) produced by the starﬁsh 
Dermasterias imbricata
15(Figure 1). In all of these compounds ovothiol or 5-thiohistidine is attached 
to a core structure via a thioether bond, indicating that the linkage occurred via nucleophilic attack of 
the thiolate onto electrophilic metabolites. For example, the biosynthesis of adenochromines has been 
suggested to occur via tyrosinase catalyzed oxidation of DOPA to dopaquinone (12, DOPA quinone), 
followed by nucleophilic attack of ovothiol to form intermediate 13.13 The fact that isolated 
adenochromines are a mixture of isomers suggests that this second step is not enzyme-catalyzed. 
Given the nucleophilicity of thiohistidines (see below) and their high concentrations in marine 
organisms, thiohistdidine adducts may be a common trait among marine natural products with 
electrophilic moieties.  
Finally, ovothiol A was also identified as a major low-molecular weight thiol in the 
protozoan Crithidia fasciculata.16 This discovery came as a surprise because it was the first indication 
that ovothiol A may not be limited to marine species. Indeed, the observation that pathogenic 
trypanosomatids such as Trypanosoma cruzi and Leishmania donovani produce ovothiol raised 
interesting questions concerning possible roles of this metabolite in human disease.17,18 The 
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identification of C. fasciculata as an ovothiol producing organism was an important prerequisite to 
study the biosynthetic origin of ovothiol (see below).  
 
 
 
 
Figure 1. Ovothiols A, B and C (1 – 3) and thiohistidine containing marine secondary metabolites 
adenochromines (4 – 6), discorhabdins (7- 9) and imbricatine (10). Box: proposed mechanism for 
tyrosinase catalyzed adenochromine biosynthesis.13 
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Biochemical properties and biological functions of ovothiol 
 
Because the thiol group of ovothiol A is attached to the 5-position of the imidazole ring, its pKa is 
much lower (pKa,SH = 1.4) than that of cysteine (pKa,SH = 8.4) and that of cysteine derivative such as 
glutathione (pKa,SH = 8.7), trypanothione (pKa,SH = 7.4), mycothiol (pKa,SH = 7.9), coenzyme A (pKa,SH 
= 9.8) or bacillithiol (pKa,SH = 8.0).
20 This unique property has led to the belief that ovothiol A may be 
a particularly efficient scavenger of peroxides.9,20 On the other hand, the disulfide of ovothiol A is 
less stable that the disulfide of glutathione. The two-electron redox potential of ovothiol A is 
considerably more positive (E° = -0.09 V vs. the standard hydrogen electrode) than that of glutathione 
(E° = -0.26V).20 Hence, the more reactive ovothiol A and the more reductive glutathione could 
cooperate to protect sea urchin eggs from hydrogen peroxide induced damage.7,21 According to this 
model, ovothiol A would first reduce peroxides by nucleophilic attack. The resulting ovothiol A 
disulfide would be reduced by glutathione and the resulting glutathione disulfide would then be 
recycled by NAD(P)H dependent glutathione reductases.20 Most ovothiol producing organisms 
contain at least one additional cysteine derivative as the major redox buffer. Therefore, peroxidase 
activity may be a general function of ovothiol. However, a quantitative analysis of the peroxidase 
activities of ovothiol A and trypanothione (E° = − 0.24 V vs. the standard hydrogen electrode) in 
trypanosomatids challenged this idea.18 This study demonstrated that trypanothione is slightly more 
reactive toward hydrogen peroxide than ovothiol A, and that the contribution of non-enzymatic 
peroxide reduction under physiological conditions is negligible. An alternative function of ovothiol A 
in trypanosomatides may be the reduction of nitrosothiols.2 This suggestion is particularly appealing 
because pathogenic trypanosomatides have to survive high concentrations of nitric oxide produced by 
macrophages in order to establish and sustain infection. Depending on how important this mechanism 
is, trypanosomal ovothiol A biosynthesis may emerge as a target for novel anti-infective therapeutics.  
The significant nucleophilicity also predestinates ovothiols as potent scavengers of carbon 
electrophiles. As indicated above, uncatalyzed ovothioylation is a likely fate of electrophilic 
metabolites in cells with high ovothiol content. The side chain of ovothiol is also characterized by a 
remarkably low one-electron redox potential (E° = 0.45 V)22 similar to that of selenocysteine (E° = 
0.43 V).23 Consequently, ovothiols may also act as free radical scavengers. A particularly interesting 
option is that ovothiol could quench oxygen superoxide (E° = 0.89 V) or radicals on proteins and 
nucleic acids (E° > 0.9 V). Unlike the thiyl radicals of cysteine-derivatives which can damage 
proteins and nucleic acids, ovothiol radicals are benign and possibly auto-quench by disulfide bond 
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formation. Moreover, thiohistidines are potent ligands for soft transition metals such as copper, zinc, 
cadmium, or mercury.24 Therefore, it is also pertinent to investigate their role in metal trafficking and 
detoxification.  
Finally, we would like to mention possible roles of ovothiol that do not directly derive from its 
chemical properties. Several observations indicate that ovothiol may also be involved in chemical 
signaling. For example, ovothiol A was reported to act as a pheromone that is secreted by the male 
marine worm P. dumerilii. Exposure to the reduced form of ovothiol A, induces the mature females 
to release their eggs.12 Another example is imbricatine (10) from D. imbricate. This secondary 
metabolite induces a “swimming response” in sea anemone, Stomphia coccinea, when they get in 
contact with the sea star.15 Another intriguing involvement of ovothiol in chemical signaling has 
been observed in the green microalgae Dunaliella salina. According to the reported observations the 
oxidized form of ovothiol A inhibits the light activated ATPase activity of the chloroplast coupling 
factor CF1.25  
 
Description of the mechanistic and structural basis for ovothiol biosynthesis.  
Pioneering experiments on cell-free extracts from C. fasciculata revealed that ovothiol biosynthesis 
starts with oxidative coupling of the side chains of cysteine and histidine to form a 
sulfoxide conjugate (14, Figure 2). This intermediate is cleaved in a pyridoxal 5-phosphate 
reaction to produce 5-thiohistidine (15) which is methylated at the proximal imidazole nitrogen 
to form ovothiol.26 A subsequent study identified the gene coding for the first enzyme in ovothiol 
biosynthesis by genome comparisons.10 In vitro reconstitution of OvoA from the plant bacterium 
Erwinia tasmaniensis, and from the pathogenic eukaryote Trypanosoma cruzi confirmed that this 
enzyme indeed catalyzes oxidative coupling of cysteine and histidine. The most surprising result of 
this finding was that ovothiol production is a much more common trait than previously thought. 
marine bacteria, including Shewanella, Photobacteria, and Pseudoalteromonas encode ovoA 
homologs consistent with the idea that ovothiol is a marine metabolite. However, ovothiol 
biosynthesis also occurs in terrestrial species living under very different conditions, such as the iron 
(III) reducing bacterium Geobacter bemidjiensis, the human pathogen Trichomonas vaginalis, the 
pathogen Erwinia amylovora, or the iron oxidizing Acidithiobacillus ferrooxidans. The broad 
distribution of ovothiol in many ecological niches raises the possibility that this metabolite can 
support cellular life in many different ways. The occurrence of ovoA genes in organisms that live 
under predominantly anaerobic conditions, such as G. bemidjiensis or T. vaginalis is of particular 
interest. Since OvoA-catalyzed ovothiol biosynthesis requires oxygen (see below), it seems possible 
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that this biosynthetic pathway is active even at very low oxygen pressures, and that ovothiols may 
support the oxygen tolerance of anaerobic organisms. Oxygen-independent biosynthesis of the 
thiohistidines has also been observed,27 but this pathway is catalyzed by an entirely different 
enzyme-type.    
 
 
Figure 2. The sulfoxide synthases OvoA (top) and EgtB (bottom) catalyze analogous oxidative C-S 
bond forming reactions to produce key intermediates in ovothiol and ergothioneine biosynthesis.  
 
OvoA is a bifunctional protein consisting of an unusual iron-dependent sulfoxide synthase at the 
N-terminus and a S-adenosyl methionine-dependent (SAM) methyltransferase at the C-terminus. 
Crystal structures of OvoA are not yet available. However, homology models of the N-terminal part 
of OvoA have been constructed based on the crystal structure of EgtB from Mycobacterium 
thermoresistibile.
28,11,29 EgtB is a sulfoxide synthase that contributes to the biosynthesis of 
ergothioneine (24, Figure 2).30 Instead of cysteine and histidine, this enzyme accepts Nα-trimethyl 
histidine (23) and γ-glutamyl cysteine as substrates. Instead of attaching sulfur to the imidazole 
Page 7 of 19 Natural Product Reports
5-position, EgtB attaches the sulfur to the 2-position (16, Figure 3). These differences, compounded 
by limited sequence identity between OvoA and EgtB (25 %) make detailed interpretation of the 
OvoA homology model difficult.  
The overall structure of the sulfoxide synthase module of OvoA is characterized by a four-helix 
bundle (DinB_2 domain) and a domain that is structurally most related to that of copper-dependent 
formylglycine-generating enzymes.31 The iron-binding active site is housed in a deep cleft between 
these two domains. So far, EgtB and OvoA are the only known enzymes with this two-domain 
architecture. Finding homologous enzymes that catalyze different reactions, or understanding why 
this particular protein architecture is exclusive to thiohistidine biosynthetic enzymes, is an 
intriguing challenges for future research.   
OvoA coordinates iron (II) by a three-histidine facial triad. After recruiting the substrates histidine, 
cysteine and oxygen to the three remaining coordination sites, the enzyme initiates carbon-sulfur 
bond formation, followed by oxygen atom transfer onto the thioether function (Figure 3). Because 
the attached oxygen atom is not retained in the final product, and is irrelevant for the two following 
reactions, sulfoxidation seems to occur only to return OvoA to the initial ferrous state. The 
mechanism by which sulfoxide synthases mediate oxygen activation and guide the activated 
intermediates along this complicated reaction trajectory are not yet clear. Structural and kinetic 
observations based on the ergothioneine biosynthetic sulfoxide synthase EgtB from M. 
thermoresistibile are suggestive of the catalytic mechanism depicted in Figure 3. Important tenets of 
this model are the following: binding of all three substrates produces an iron (III)-superoxo species 
(17, Figure 3); proton transfer from an active site tyrosine (Tyr377) to this species facilitates 
oxidation of the substrate cysteine to a thiyl radical (18) which then attacks the imidazole ring of the 
second substrate (A, Figure 3).32,33 Oxygen transfer and deprotonation of this intermediate (19) 
complete the reaction cycle. This model has been challenged by two independent computational 
studies.  
One study based on density functional theory (DFT)34, and one based on combined quantum and 
molecular mechanics (QM/MM)35 explored different sequences of the elementary steps and an 
alternative role of Tyr377. The DFT study concluded that species 17 directly transfers an oxygen 
atom to the sulfur atom of γ-glutamyl cysteine (25, Figure 3), and consequently, that the imidazole 
ring of Nα-trimethyl histidine is attacked by the sulfinyl rather than the thiyl radical (26). One 
problem of this mechanism is that the stereochemistry of the resulting sulfoxide product (27) is 
inconsistent with the empirically determined structure of the EgtB product 16.32 The QM/MM study 
raised the possibility that Tyr377 could transfer a hydrogen atom to species 17 to produce an iron 
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hydroperoxo species and a tyrosyl radical (28). It is not yet clear, whether this species can directly 
lead to C-S bond formation (29), or whether it may be an off-pathway species that equilibrates with 
species 17. 
Arbitration between these competing proposals may come from parallel characterization of distant 
EgtB homologs such as OvoA. Despite low sequence similarity and different physiological 
functions, OvoA shares key functional features with EgtB. For example, OvoA can also accept 
TMH as a substrate and attaches the cysteine sulfur atom to the 2-position instead of the 5-position 
on the imidazole ring.36 The resulting product is an ergothioneine precursor. Inherent EgtB-like side 
activity of OvoA may have enabled certain cyanobactertia to recruit an ancient OvoA-homolog for 
ergothioneine biosynthesis.37 Characterization of an OvoA homolog from Microcystis aeruginosa 
revealed that this enzyme lost its ability to make ovothiol and instead became a proficient EgtB 
ortholog. Functional adaptation required so few mutations that ergothioneine making and ovothiol 
making OvoA homologs cannot be distinguished based on global sequence similarity. Facile 
transition between EgtB- and OvoA-like activity suggests that that the catalytic mechanisms of the 
two types of sulfoxide synthase are essentially the same.   
A recent study confirmed that OvoA contains a structurally equivalent active site tyrosine (Tyr417) 
that plays the same pivotal role as Tyr377 in EgtB.38 This study also showed that this Tyr residue 
could be substituted with the non-natural tyrosine derivative 
2-amino-3-(4-hydroxy-3-(methylthio)phenyl)propanoic acid (MtTyr) using stop-codon suppression 
technology. This non-natural mutation resulted in decreased sulfoxide synthase activity, suggesting 
that even minimal perturbation at this site interferes with catalysis. The ability to modulate the 
active sites of sulfoxide synthases with atomic precision may prove an invaluable tool to decipher 
the catalytic mechanism of these enzymes. 
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Figure 3. Proposed reaction mechanism of EgtB (A). A similar mechanism could be formulated for 
OvoA (B). Alternative models of EgtB catalysis proposed based on DFT (C) or QM/MM 
calculations (D). 
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The second reaction in ovothiol biosynthesis is catalyzed by a PLP- dependent β-lyase.39 
Comparison of OvoA encoding genomes from many organisms did not reveal any gene coding for a 
β-lyase exclusively dedicated to ovothiol biosynthesis. Given that β-elimination of cysteine 
S-conjugates is a fairly simple and a very common reaction, it is possible that most organisms use 
unspecific β-lyases to support ovothiol production. The last step is methylation of 5-thiohistidine 
(15) at Nπ of the imidazole ring. This SAM-dependent reaction is catalyzed by the C-terminal 
domain of OvoA (Misson, Liao Seebeck, unpublished). The methyltransferases that can methylate 
the α-amino group of ovothiol A to form ovothiol B and C (Figure 1) are not yet known.  
Based on what we currently known about ovothiol A-biosynthetic enzymes, we can conclude 
that ovothiol emerges from a remarkably simple biosynthetic pathway that starts with a very 
complicated carbon-sulfur bond forming reaction. Cellular ovothiol production depends on a single 
polypeptide that encodes both essential enzymatic activities. This simplicity may have facilitated 
dissemination of this biological trait by horizontal gene transfer. Once fully understood this 
enzymatic machinery should provide a robust platform for the biotechnological production of this 
potential therapeutic natural product. An alternative way to produce ovothiol would be total 
chemical synthesis. The different synthetic routes explored so far remain cumbersome.40,41,42,43 
Most importantly, two recent studies showed that 5-thiohistidine (15) and ovothiol A can be made 
from the natural precursor L-histidine following relatively simple 2- and 5-step syntheses.43,44 
 
Insight into the evolutionary history of the ovothiol biosynthetic pathway.  
 
Definitive identification of ovothiol biosynthetic enzymes cleared the view over the distribution of 
ovothiol production activity across the tree of life. Close analysis of this distribution provides an 
alternative approach to understanding the cellular function of ovothiol.  
The distribution of ovoA genes among microorganisms follows a very complex pattern. Bacteria 
and lower eukaryotes inhabiting very different ecological niches appear to have acquired this gene 
by horizontal gene transfer driven by evolutionary pressures that may be different for each 
individual genus or species. The most interesting question here is as to when and in what species 
OvoA-like sulfoxide synthases diverged from EgtB-like enzymes to make ovothiol instead of 
ergothioneine. Because this event may date back almost two to three billion years, this will be a 
challenging question to answer solely based on sequence comparisons.  
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The evolutionary history of ovothiol biosynthesis in metazoans is interesting for another reason.  
Analysis of metazoans’ genomes revealed that ovoA is highly conserved in marine metazoans, from 
Porifera to Placozoa, Cnidaria, protostomes and deuterostomes.11 Among deuterostomes, ovoA is 
conserved in Echinodermata and Hemichordata, Cephalochordata, Urochordata, and in 
Chondrichthyes (Figure 4). Interestingly, the ovoA gene has been lost at least at two key events in 
metazoan evolution (red cross, Figure 4). One such event occurred in ancestral ecdysozoa 
(nematodes and arthropods) rendering most of terrestrial species – insects, for example – unable to 
make ovothiol. This pattern indicates that loss of ovothiol production may be related to the 
transition from an aquatic to a terrestrial life-style.  
Another gene-loss event traced to the last common ancestor of Osteichthyes fish.11 This loss does 
not necessarily mean that fish lost their appetite for ovothiol. In fact, ovothiols have been reported 
to be found also in the eggs of the rainbow trout, Salmo gairdneri, as well as from the eggs of the 
Coho salmon, Oncorhynchus kisutch.45 Most likely these higher animals acquire ovothiol through 
their nutrition, which in the case of salmon includes ovothiol producing mollusks and crustaceans. 
In a way, it seems that bony fish simply out-sourced ovothiol production down the food chain but 
still rely on this antioxidant as a micro-nutrient or a vitamin. This interpretation highlights an 
interesting analogy to the distribution of ergothioneine and ergothioneine producing genes in 
terrestrial species. A growing number of observations document the physiological importance of 
ergothioneine in human physiology.46 However, higher eukaryotes including most plants and 
animals do not synthesize ergothioneine on their own, but they acquire this metabolite from their 
nutrition by way of an ergothioneine-specific transporter protein.47 Meanwhile, production of 
ergothioneine is almost exclusively a bacterial and a fungal activity. If ovothiol is indeed a 
micro-nutrient for bony fish, there should be a specific ovothiol transporter protein. Identification of 
the corresponding gene would pave the way to examine the localization, regulation and 
developmental significance of ovothiol in in higher animals. It is clear that such an investigation 
would produce important insight as to how ovothiol may be exploited as a therapeutic compound. A 
comprehensive overview of the evolutionary history of metazoan ovoA genes may also help to 
identify other events of ovoA gene loss, duplication and diversification. A third objective for future 
investigations may be addressing the question as to when and from where the ovoA gene entered 
the metazoan lineage.   
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Figure 4. Scheme of phylogenetic distribution of OvoA in metazoans. 
 
 
Unravelling the biological roles of ovothiols  
The genomic structure of - such as the exon–intron boundaries - and transcriptional regulation of the 
ovoA gene P. lividus has been characterized recently.11 This analysis highlighted that the 
biosynthesis of ovothiol is important during fertilization as well as during larval development. After 
the consumption of maternal ovoA transcript, embryos start ovoA transcription at the pluteus stage, 
the time when larva starts to reorganize its body plan to go in metamorphosis. Throughout sea 
urchin development, ovoA transcription is regulated by metals and toxic algal blooms.11 This 
regulatory link between chemical stress and ovothiol production makes much sense. Sea urchins are 
broadcast spawners, meaning they release gametes in the seawater column where fertilization and 
embryo development occur. In this environment vulnerable embryos and larvae are exposed to 
many kinds of organic or inorganic toxins which can induce oxidative stress. Hence, active 
up-regulation of ovoA in the pluteus stage suggests that ovothiol protects cells not only during the 
post-fertilization oxidative burst, but also in later stages, regulated by redox-sensitive pathways.  
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Recently ovoA transcription was also found to be up-regulated in Nematostella vectensis (starlet 
sea anemone), in response to dispersant and/or sweet crude oil exposure alone or combined with 
ultraviolet radiation (UV).48 These data confirm the involvement of this metabolic pathway in the 
defence mechanisms from environmental factors and highlight the importance of these sulphur- 
containing amino acids for UVA protection in area more exposed to radiation such as the poles. 
In Euglena gracilis, a highly complex alga belonging to the green plants, different ovoA 
transcripts have been identified through the analysis of its transcriptome.49 In particular, a complete 
transcript covering all the three characteristic domains of OvoA, has been found during algal cell 
growth in dark conditions, whereas two different sequences, one covering the OvoA N-terminal 
domain and one covering the OvoA C-terminal domain were detected in both dark and light transcript 
sets. It will be very intriguing to investigate in the future whether this pathway can be finely regulated 
at the transcriptional level depending on the light dark cycle, or if these different transcripts encode 
for different enzymatic activities. Overall these studies suggest that ovothiol me be involved in 
plasticity response of organisms to the changing conditions of the environment. 
The increasing availability of new genomes and of relevant amounts of transcriptomic data for 
different marine species, for what concerns both adult tissues, tissues subject to biotic and abiotic 
stress, and larval stages, will allow in the next future to comparatively investigate the tissue 
distribution of OvoA transcript, its regulation under different conditions and to give insight into 
ovothiol function. Moreover, thanks to the fundamental developments of advanced gene technology 
applied to marine organisms50, all the old theories on the biological function of ovothiol and related 
marine thiohistidines may be revised, opening new concepts and ideas. 
 
 
Therapeutic potential of ovothiols 
Discovery of compounds with therapeutic potential is one of the main objective of natural product 
research. In this quest the ocean has emerged as a nearly unlimited resource. Since its discovery, 
ovothiol has already attracted some interested as a possible therapeutic.51 However, because the 
proper roles of ovothiol are still somewhat obscure, we believe that the therapeutic potential of 
ovothiol is still largely underappreciated. In addition, because humans and other terrestrial 
vertebrates do not biosynthesize or require ovothiol, it is possible that OvoA is a valid target to treat 
infections by pathogenic microorganisms, including Trypanosoma, Leishmania or Trichomona. 
Advances in these directions clearly hinge on progress in understanding of ovothiol and ovothiol 
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biosynthetic enzymes in their cellular context. In the following we will summarize the current 
approaches to valorizing ovothiol.  
The first study to investigate the biological activity of ovothiol derivatives demonstrated that the 
ovothiol derivative 1-methyl-2-[3-trifluoromethyl-phenyl]-4-mercapto-imidazole (MFP-4MI) is a 
neuroprotective agent for the mammalian brain. Mice exposed to oxidative stress caused by 
magnesium deficient diet and treated with the reduced form of MFP-4MI resulted in anticonvulsant 
protection when exposed to an auditory signal inducing a sound-produced seizure. Moreover, the 
compound inhibited cell death in grey and white matter and reduced brain injury.52 The finding that 
the oxidized form of the compound, exhibited in vivo cerebroprotective properties similar to those 
of the reduced form, led to the identification of several recycling mechanisms consistent with the 
conversion of the oxidized to the reduced compound, and providing strong evidence that recycling 
(thiol-disulphide exchange) properties of the oxidized form are involved in modulating 
neuroprotective processes in the same way of the antioxidant reduced form.  
 
 
 
Figure 5. Disulfide of ovothiol A (30)  
 
Recently, ovothiol A (1), purified from P. lividus eggs in its disulfide form (30, Figure 5), have been 
also shown to induce a decrease in cell proliferation with the concomitant activation of an autophagic 
process in human hepatocarcinoma cell lines, Hep-G253, thus suggesting a potential role of the 
molecule in the regulation of tumor cell growth. Autophagy is a finely regulated catabolic process, 
often associated to nutrient deprivation, which cells can adopt to survive under stress conditions or 
self-suicide. Changes in the autophagic process are the cause of many pathological conditions, 
including liver diseases and some types of cancer.54 Whereas it has been previously demonstrated 
ovothiol A, administered in the form of disulfide in human cells, is reduced by the GSH/GSSG 
system within the cell52 this may not be the case of Hep-G2, in which ovothiol could not enter cancer 
cells. This hypothesis was supported by the finding that ovothiol was not detected inside in the cells, 
and was not able to reduce reactive oxygen species.53 In this case, it is very likely that ovothiol A 
interact with a membrane surface protein, and subsequently induce a molecular pathway leading to 
autophagy. Considering that ovothiol A is a modified amino acid, it will be very interesting to 
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its potential involvement in recycling of amino acids inside the cells and in inducing protein 
synthesis, two processes both involved in cell proliferation and autophagic mechanisms.  
However, ovothiol A plays pleiotropic activities depending on cellular systems and different 
molecular targets affected. When evaluating the effects of the marine-derived ovothiol A in an in 
vitro cellular model of pathology associated to chronic low-grade inflammation and oxidative 
stress, the molecule adopts a different behavior, resembling that of an antioxidant.55 Diabetes is one 
of the most widespread pathology associated with oxidative stress and vascular chronic 
inflammation, alterations underlying the development of cardiovascular disease. Endothelial 
dysfunction is the main cause of cardiovascular disease development and is characterized by an 
increased expression of endothelial adhesion molecules and the recruitment of monocytes in the 
intima, a pivotal and critical event in promoting atherosclerosis. In an in vitro model of 
hyperglicemia-induced endothelial dysfunction, that is human umbilical vein endothelial cells from 
women suffering from gestational diabetes and from healthy mothers, ovothiol A in its disulfide 
form was rapidly taken up by both cell types, and partially reduced inside, most likely by redox 
exchange with GSH/GSSG cellular system.55 In this case, in fact, ovothiol A seems to act as an 
antioxidant partially scavenging ROS and peroxynitrite and making NO freely to modulate 
endothelium functionality. The maintenance of endothelial NO bioavailability is indeed considered 
beneficial to endothelial functions and more in general to vascular health because it counteracts the 
pro-inflammatory response in the early stages of atherosclerosis, especially during chronic 
hyperglicemia. This effect was more evident when cells were stimulated with Tumor Necrosis 
Factor-α (TNF-α), and ovothiol A induced a significant down-regulation of adhesion molecules, 
responsible for the reduction of monocyte–endothelium interaction.53 These results pointed to the 
potential anti-atherogenic properties of the natural antioxidant ovothiol A, and highlight its 
therapeutic potential in pathologies related to cardiovascular diseases associated to 
oxidative/inflammatory stress and endothelial dysfunction.  
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Conclusions 
Ovothiol A (1) and its derivatives B (2) and C (3) are fascinating sulfur natural products with 
unique chemical properties. 5-thiohistidines behave as excellent nucleophiles and as reducing 
agents that in principle may protect cells from reactive oxygen and nitrogen species, electrophilic 
organic compounds and thiophilic metals. However, elucidating the biological role of ovothiol in 
marine organisms will also require systematic analysis of the distribution and regulation of proteins 
that make, transport and interact with ovothiol. The discovery of ovothiol biosynthetic genes 
showed that ovothiol production is a frequent trait in marine bacteria and metazoans. Description of 
the transcriptional activity of the ovoA gene in larval stages of sea urchins indicated that protection 
by ovothiol is not limited to the post-fertilization events. Identification of ovothiol as a regulatory 
factor in green microalgae suggests that ovothiol can interact with proteins - likely by forming mixed 
disulfide bonds with surface cysteines. Finally, finding of ovothiol from salmon – a bony fish that 
encodes no ovoA gene – suggests that higher animals may acquire ovothiol as a micro-nutrient, 
presumably through an ovothiol-specific transporter protein. These are intriguing leads, suggesting 
that ovothiol is a ubiquitous and highly integrated component in marine biochemistry. Advances in 
these directions will illuminate the complex role of ovothiol. This research will also address the 
question as to, why ovothiol is much more abundant in marine ecosystems than in terrestrial 
ecosystems. Also, mechanistic appreciation of cellular ovothiol function would provide a platform to 
evaluate and validate the therapeutic potential of this marine natural product.  
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